Olanzapine pamoate

Product Description
Inke S.A.

-
ES
-
2017On CPHI since
-
100 - 249Employees
Company types
Categories
Inke S.A.

-
ES
-
2017On CPHI since
-
100 - 249Employees
Company types
More Products from Inke S.A. (45)
-
Product Imidapril
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Imidapril. Indication: Hypertension
EU DMF -
Product Indacaterol maleate
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Indacaterol. Indications Asthma and COPD
EU and US DMF available -
Product Loratadine
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Loratadine. Indication: Allergy
JP DMF
-
Product Montelukast sodium
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Montelukast sodium. Indication: Asthma, allergic and seasonal rhinitis
EU and JP DMF -
Product Nitrendipine
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Nitrendipine. Indication: Hypertension
CEP an DMF
-
Product Olanzapine
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Olanzapine. Indications: Schizophrenia, psychosis
EU and US DMF
-
Product Olodaterol
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Olodaterol. Indication COPD -
Product Ondansetron base
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Ondansetron base. Indication: Emesis
EU-US DMF -
Product Ondansetron hydrochloride
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Ondansetron hydrochloride. Indication: Emesis
CEP and US DMF -
Product Prasugrel base
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Prasugrel base. Indication: Prophylaxis and therapy of thrombosis
EU DMF -
Product Quetiapine hemifumarate
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Quetiapine hemifumarate. Indication: Schizophrenia, psychosis
JP and KR DMF -
Product Revefenacin
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Revefenacin for COPD treatment
Inke S.A. resources (1)
-
Brochure INKE PORTFOLIO AND PIPELINE
Inke is a Barcelona-based company with an FDA approved plant, we develop and manufacture APIs with complex synthesis process mostly for Respiratory diseases (Inhalation) and also CNS , among other therapeutically areas.
INKE has several DMFs approved already in the US-FDA and we are already supplying to some local and multinational pharmaceutical companies worldwide.
Frequently Viewed Together
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance